Smarter drug testing targets fast-changing synthetic cannabinoids
Detection of drugs of abuse: evolving analytical strategies and emerging challenges.
AI Summary
This review examines how laboratories and clinicians detect drugs in biological samples such as urine, blood, hair, and oral fluid. Each specimen offers a different detection window: urine and blood generally reflect more recent use, hair can preserve evidence over a longer period, and oral fluid can indicate recent intake. The paper compares established chromatographic and mass spectrometric methods with newer electrochemical, optical, and biosensor technologies. The abstract reports no quantitative results or pooled performance estimates.
A major focus is the difficulty of identifying rapidly changing new psychoactive substances, including synthetic cannabinoids, cathinones, hallucinogens, and amphetamine-type stimulants. These compounds may be designed to evade regulation and complicate conventional testing. The review supports a two-tiered testing strategy: fast, portable screening in the field followed by highly selective laboratory confirmation. For cannabis users and public-health programs, this approach could improve the practicality of detecting synthetic cannabinoid exposure while helping distinguish preliminary results from confirmed findings.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
Treatment records show a sharp rise in stimulant use in Oman, 2019β2024
An 18-month cohort found adverse outcomes were infrequent, but long-term risksβ¦
Barcelona survey links teen pornography use with cannabis use and other outcomes
Explore More Research
Stay informed about the latest cannabis science.